Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ryanair Holdings plc (RYAAY) vs Tempus AI (TEM) Price & Performance

Ryanair Holdings plcTrade

Price performance (Past 24H)

Key statistics

Ryanair Holdings plc vs Tempus AI — how do they compare? Ryanair Holdings plc trades at $54.19 (market cap $27.58B), while Tempus AI trades at $61.12 (market cap $11.67B). The key difference: Ryanair Holdings plc is far larger — about 2.4× Tempus AI's market cap, and Ryanair Holdings plc pays a 1.65% dividend while Tempus AI pays none. Which is the better fit depends on your goals.

RYAAYTEM
Market Cap
$27.58B$11.67B
Sector
IndustrialsBroad Market / Factor
52-Week High
$73.82$103.25
52-Week Low
$53.24$41.55
Enterprise Value
$24.53B$12.30B
Dividend Yield
1.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ryanair Holdings plc

RYAAY trades at $54.37, down 1.79% on the day, with a bearish technical signal from moving averages. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing strong revenue growth trends. Recent news highlights operational challenges including traffic outlook reductions and cost pressures from unhedged fuel. Cash flow remains positive from operations but net cash flow turned negative in 2025 and 2026 projections.

The outlook is cautious due to near-term headwinds from fuel costs and competitive pricing, but long-term fundamentals remain solid with attractive valuation multiples. Investment opportunity exists for value-oriented investors given low P/E of 13.09 and strong profitability metrics. Key risks include oil price volatility and winter capacity constraints affecting profitability.

Tempus AI

Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).

Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.

Returns comparison

Trailing returns across standard periods

About Ryanair Holdings plc

Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.

Read more on RYAAY

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM